ANGPTL3 and Other metabolic disease: Collectively, these findings reveal a novel miR-181d–ANGPTL3 axis that has a vital role in regulating lipid metabolism, and they suggest a potential role for miR-181d in therapy targeting dysregulated lipid metabolism in metabolic diseases.